MSB

10.4%

$1.49 mesoblast limited

I'm calling it..., page-10

First 10 Last

Share
Profile

Follow
onetricky

15,143 Posts.

1000

04/05/17

19:15

Post #: 24481119
Share

Originally posted by madamswer ↑

Originally posted by madamswer ↑

(This forum is like no other in terms of its degree of absurdity at times.)

Before the start of this week, the share had risen in price, from 7-year low levels in June 2016, by three-fold. And since the start of the calendar year it had risen by almost 150%.

But when it one day starts to give up some of those dramatic gains, all manner of conspiracy theories are offered up and all sorts of speculation breaks out in attempts to explain why.

Yet the one thing that is never mentioned as a reason is the very reasonable possibility that some investor(s) happened to achieve the perfectly normal and rational objective of buying low and selling high.

Surely it isn't beyond the realms of possibility that stock that was purchased at a price under half what it is today is now being sold, for purposes of recording a profit?

What - I wonder - is so totally implausible about that that explanation that it doesn't warrant consideration?

Expand

(This forum is like no other in terms of its degree of absurdity at times.)

Before the start of this week, the share had risen in price, from 7-year low levels in June 2016, by three-fold. And since the start of the calendar year it had risen by almost 150%.

But when it one day starts to give up some of those dramatic gains, all manner of conspiracy theories are offered up and all sorts of speculation breaks out in attempts to explain why.

Yet the one thing that is never mentioned as a reason is the very reasonable possibility that some investor(s) happened to achieve the perfectly normal and rational objective of buying low and selling high.

Surely it isn't beyond the realms of possibility that stock that was purchased at a price under half what it is today is now being sold, for purposes of recording a profit?

What - I wonder - is so totally implausible about that that explanation that it doesn't warrant consideration?

Expand

i note you was posting at $1.50 when i was last here, went to $3+
you didn't trade it?

MSB Price at posting: $2.69 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 52 more messages in this thread...

First 10 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.49		Change 0.140(10.4%)		Mkt cap ! $1.701B

Open	High	Low	Value	Volume
$1.37	$1.54	$1.37	$23.10M	15.82M

Buyers (Bids)

No.	Vol.	Price($)
3	24758	$1.49

Sellers (Offers)

Price($)	Vol.	No.
$1.49	73626	3

View Market Depth

No.	Vol.	Price($)
1	10033	1.485
4	53700	1.480
1	770	1.475
3	62048	1.460
1	50000	1.455

Price($)	Vol.	No.
1.490	21995	1
1.505	24000	1
1.510	13666	2
1.515	99798	1
1.520	27250	3

Last trade - 16.10pm 04/10/2024 (20 minute delay)

MSB (ASX) Chart

I'm calling it..., page-10

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I'm calling it..., page-10

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News